STRS Ohio’s GSK GSK Stock Holding History

STRS Ohio’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-148,640	Closed	-$9.32M	–	1766
2013 Q3	$9.32M	Sell	148,640 -58,344	-28%	-$3.76M	0.04%	415
2013 Q2	$12.9M	Buy	+206,984	New	+$13.1M	0.06%	371

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

STRS Ohio's GSK Position: Q4 2013 in Review

STRS Ohio sold out of GSK (GSK) in Q4 2013, closing a stake of 148,640 shares — an estimated $9.32M sold.

STRS Ohio first reported a position in GSK in Q2 2013 and held it in 2 quarters. The position peaked at $12.9M in Q2 2013. 681 funds tracked by Wall St. Rank hold GSK as of Q4 2013.

STRS Ohio reported no remaining GSK position as of Q4 2013 after selling out during the quarter.
STRS Ohio sold 148,640 GSK shares in Q4 2013, an estimated $9.32M.
STRS Ohio first reported a position in GSK in Q2 2013 and held it in 2 quarters.
STRS Ohio's GSK position peaked at $12.9M in Q2 2013.
681 funds tracked by Wall St. Rank held GSK as of Q4 2013.

Based on STRS Ohio's 13F filing for Q4 2013, filed 30 Jan 2014.